Cleared Traditional

K854678 - ERMA PC-602 PC-603 BLOOD CELL COUNTER

K854678 is the FDA 510(k) clearance for ERMA PC-602 PC-603 BLOOD CELL COUNTER by Future Impex Corp.. It is a Class 2 Hematology device (product code GKL) cleared through the Traditional 510(k) pathway after a 81-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1986
Decision
81d
Days
Class 2
Risk

K854678 is an FDA 510(k) clearance for the ERMA PC-602 PC-603 BLOOD CELL COUNTER. Classified as Counter, Cell, Automated (particle Counter) (product code GKL), Class II - Special Controls.

Submitted by Future Impex Corp. (Deerpark, US). The FDA issued a Cleared decision on February 24, 1986 after a review of 81 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5200 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Future Impex Corp. devices

Submission Details

510(k) Number K854678 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1985
Decision Date February 24, 1986
Days to Decision 81 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
32d faster than avg
Panel avg: 113d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKL Counter, Cell, Automated (particle Counter)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKL Counter, Cell, Automated (particle Counter)

All 47
Devices cleared under the same product code (GKL) and FDA review panel - the closest regulatory comparables to K854678.
IL CELLECT 7
K863290 · Instrumentation Laboratory CO · Sep 1986
IL CELLECT 8
K863291 · Instrumentation Laboratory CO · Sep 1986
COULTER COUNTER MODEL S PLUS JUNIOR
K861780 · Coulter Electronics, Inc. · Aug 1986
TECHNICON H*1 SYSTEM (HDW)
K853030 · Technicon Instruments Corp. · Feb 1986
COULTER COUNTER MODEL T-660
K854114 · Coulter Electronics, Inc. · Nov 1985
COULTER COUNTER MODEL M5
K853429 · Coulter Electronics, Inc. · Oct 1985